S
Scott M. Grundy
Researcher at University of Texas Southwestern Medical Center
Publications - 849
Citations - 246629
Scott M. Grundy is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 187, co-authored 841 publications receiving 231821 citations. Previous affiliations of Scott M. Grundy include University of California, San Francisco & University of California, Davis.
Papers
More filters
Journal ArticleDOI
Cholesterol-lowering drugs as cardioprotective agents.
TL;DR: The appropriate use and benefits of bile acid sequestrants, nicotinic acid, fibric acids, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, and probucol are individually discussed, whereas nonpharmacologic approaches used in conjunction with the drugs are recommended emphatically.
Journal ArticleDOI
Persistence of abnormalities in metabolism of apolipoproteins B-100 and A-I after weight reduction in patients with primary hypertriglyceridemia.
TL;DR: To determine whether weight reduction will normalize lipoprotein metabolism in overweight, hypertriglyceridemic patients, 10 such male patients underwent weight loss until their body weights were within the desirable range, and measurements were made of plasma lipid, lipop protein, and apolipoprotein levels and the kinetics.
Association for the Study of Obesity Heart Federation; International Atherosclerosis Society; and International National Heart, Lung, and Blood Institute; American Heart Association; World International Diabetes Federation Task Force on Epidemiology and Prevention; Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the
Journal ArticleDOI
Management of high serum cholesterol and related disorders in patients at risk for coronary heart disease
TL;DR: Nondrug measures, bile acid sequestrants, nicotinic acid, and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors all play important roles in cholesterol-lowering therapy.
Journal ArticleDOI
Incorporation of radioactive phospholipid into subclasses of high-density lipoproteins
TL;DR: The results show preferential transfer or exchange or absorbed phosphatidylcholine into specific subclasses of HDL, corresponding to the subclass previously designated HDL2a and HDL2b.